Floatz logo

Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
CDX 1140
Malignant Pancreatic Neoplasm
Washington University School of MedicineP2CCC (51)
PANTOPRAZOLE
Malignant Pancreatic Neoplasm
Washington University School of MedicineP2CCC (51)
Pegargiminase
Small Cell Lung Carcinoma
Washington University School of MedicineP2CCC (51)
TZ-3321
Metastatic Malignant Neoplasm In The Brain
Washington University School of MedicineP2CCC (51)
flt3 ligand
Cancer of the Pancreas
Washington University School of MedicineP2CCC (50)
Plerixafor
Childhood Acute Myeloid Leukemia
Washington University School of MedicineP1/2CCC (50)
n-803
Non Small Cell Lung Cancer
Washington University School of MedicineP3CCC (49)
Cytokine-Induced Memory-Like Nk Cells
Myelodysplastic Syndrome
Washington University School of MedicineP2CCC (48)
Dasatinib
Schizophrenia
Washington University School of MedicineP2CCC (48)
Empagliflozin
HER2 Positive Breast Carcinoma
Washington University School of MedicineP2CCC (48)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Schizophrenia
Washington University School of MedicineP2CCC (48)
LEMBOREXANT
Alzheimer Disease
Washington University School of MedicineP2CCC (48)
Vigabatrin
Obesity Disorder
Washington University School of MedicineP2CCC (48)
CYCLOSPORIN A
Metabolic Disorders
Washington University School of MedicineP1/2CCC (48)
CYCLOSPORIN A
Non-malignant Disorders
Washington University School of MedicineP1/2CCC (48)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301)
Gastrointestinal Stromal Tumor
Washington University School of MedicineP1/2CCC (48)
Evomela
Non-malignant Disorders
Washington University School of MedicineP1/2CCC (48)
Fludarabine
Non-malignant Disorders
Washington University School of MedicineP1/2CCC (48)
Hydroxyurea
Immunologic Disorders
Washington University School of MedicineP1/2CCC (48)
Hydroxyurea
Metabolic Disorders
Washington University School of MedicineP1/2CCC (48)
Hydroxyurea
Non-malignant Disorders
Washington University School of MedicineP1/2CCC (48)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Non-malignant Disorders
Washington University School of MedicineP1/2CCC (48)
METHOTREXATE
Immunologic Disorders
Washington University School of MedicineP1/2CCC (48)
METHOTREXATE
Metabolic Disorders
Washington University School of MedicineP1/2CCC (48)
METHOTREXATE
Non-malignant Disorders
Washington University School of MedicineP1/2CCC (48)
Showing 126 to 150 of 278 assets
PreviousPage 6 of 12Next